Immuron Limited (NASDAQ: IMRN) (ASX: IMC) Emerging Growth Research Report – April 22, 2026

Immuron reported solid revenue growth for the third quarter of its 2026 fiscal year, ended March 31, 2026. Global sales were AUD $1.5 million, a 16% increase over the prior year’s quarter. Looking ahead, we expect continued high single-digit to low double-digit revenue growth in the U.S. and Australia, supplemented by a higher growth rate in Canada, albeit on lower absolute dollar volumes.